lidocaine 0.05 MG/MG Medicated Patch [Lidoderm]
- RxCUI
- 1011705
- RxNorm name
- lidocaine 0.05 MG/MG Medicated Patch [Lidoderm]
- Display name
- LIDODERM (Topical)
- Full name
- lidocaine 0.05 MG/MG Medicated Patch [Lidoderm]
- Term type
- SBD
- Status
- Active
- Strength
- 5%
- Dose form
- Medicated Patch
- Route
- Topical
- Updated
- 2026-10-24 12:25:51
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102010
- Active start
- 102010
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| lidocaine | 0.05 MG / 1 MG | lidocaine | lidocaine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Medicated Patch | 1792831 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| lidocaine | 6387 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Lidoderm 5 % Medicated Patch | 1 | NAMES |
| RxNorm Name | lidocaine 0.05 MG/MG Medicated Patch [Lidoderm] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | db0092f5-02a0-4076-ac32-969f075a6ab1 | 1 | CODES |
| RxCUI | 1011705 | 1 | CODES |
| MMSL_CODE | BD7003 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 61959-001-30 | 61959-001 | LIDODERM Lidocaine Patch 5% | TPU Pharma, Inc. | NDA020612 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIDODERM | LIDOCAINE PATCH 5% | TPU Pharma, Inc. | db0092f5-02a0-4076-ac32-969f075a6ab1 | 2022-12-02 | Warnings, Adverse reactions | 61959-001-30 61959-001 61959000101 61959000130 1011705 |
| Lidocaine | LIDOCAINE | Actavis Pharma, Inc. | 4d04052c-3e0a-469a-9265-99604f13e507 | 2022-04-30 | Warnings, Adverse reactions | 00591352530 00591352511 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d499efc5-8bc3-4dbc-9d85-fae57dd9263c | Lidoderm 5 % Medicated Patch [PSN] · lidocaine 0.05 MG/MG Medicated Patch [Lidoderm] [SBD] · Lidoderm 0.05 MG/MG Medicated Patch [SY] · Lidoderm 5 % Medicated Patch [SY] | 4 | 5 | LIDODERM® (Lidocaine Patch 5%) | 20171212 |
| 4e45cd6c-a777-4100-943b-985058bff75a | Lidoderm 5 % Medicated Patch [PSN] · lidocaine 0.05 MG/MG Medicated Patch [Lidoderm] [SBD] · Lidoderm 0.05 MG/MG Medicated Patch [SY] · Lidoderm 5 % Medicated Patch [SY] | 4 | 4 | LIDODERM® (Lidocaine Patch 5%) | 20120202 |
| db0092f5-02a0-4076-ac32-969f075a6ab1 | Lidoderm 5 % Medicated Patch [PSN] · lidocaine 0.05 MG/MG Medicated Patch [Lidoderm] [SBD] · Lidoderm 0.05 MG/MG Medicated Patch [SY] · Lidoderm 5 % Medicated Patch [SY] | 4 | 3 | LIDODERM® (Lidocaine Patch 5%) | 20221202 |
| 5ffefcdc-ebfa-4dc8-b484-719658da9d6d | Lidoderm 5 % Medicated Patch [PSN] · lidocaine 0.05 MG/MG Medicated Patch [Lidoderm] [SBD] · Lidoderm 0.05 MG/MG Medicated Patch [SY] · Lidoderm 5 % Medicated Patch [SY] | 4 | 2 | 20100524 | |
| 55be87b4-a69b-4bfd-bf92-2949ec5e5dab | Lidoderm 5 % Medicated Patch [PSN] · lidocaine 0.05 MG/MG Medicated Patch [Lidoderm] [SBD] · Lidoderm 0.05 MG/MG Medicated Patch [SY] · Lidoderm 5 % Medicated Patch [SY] | 4 | 1 | LIDODERM® (Lidocaine Patch 5%) | 20111005 |
| 7ab30afe-4de2-4fe5-9e62-a484683fb93f | Lidoderm 5 % Medicated Patch [PSN] · lidocaine 0.05 MG/MG Medicated Patch [Lidoderm] [SBD] · Lidoderm 0.05 MG/MG Medicated Patch [SY] · Lidoderm 5 % Medicated Patch [SY] | 4 | 1 | LIDODERM® (Lidocaine Patch 5%) | 20110721 |
| 18e420b9-0fd1-48d9-9a23-c1e29a5f629f | Lidoderm 5 % Medicated Patch [PSN] · lidocaine 0.05 MG/MG Medicated Patch [Lidoderm] [SBD] · Lidoderm 0.05 MG/MG Medicated Patch [SY] · Lidoderm 5 % Medicated Patch [SY] | 4 | 1 | LIDODERM® (Lidocaine Patch 5%) | 20100201 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| db0092f5-02a0-4076-ac32-969f075a6ab1 | LIDODERM® (Lidocaine Patch 5%) | TPU Pharma, Inc. | 20221202 |
| f1c40164-4626-4290-9012-c00e33420a33 | LIDODERM® (Lidocaine Patch 5%) | Endo Pharmaceuticals Inc. | TEIKOKU SEIYAKU CO.,LTD. | 20221127 |
| 4d04052c-3e0a-469a-9265-99604f13e507 | Lidocaine Patch A200675 | Actavis Pharma, Inc. | 20220430 |
| a97a3c99-66f6-2077-e053-2a95a90a1ce7 | Prilo Patch-II (lidocaine and prilocaine cream, lidocaine patch and isopropyl alcohol) | PureTek Corporation | 20211008 |
| 38659ed2-0274-490a-9bc5-70e1c96e3fc9 | Zilacaine Patch™ (lidocaine patch, silicone scar gel dressings and disposable medical scissors) Rx Only | PureTek Corporation | Actavis Laboratories UT, Inc. | 20210330 |
| e804fe2e-00c0-4e28-8d7d-28ac6f1cac5f | Gabacaine These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 | PureTek Corporation | Actavis Laboratories UT, Inc. | 20201116 |
| 85174497-dddb-ae3d-e053-2991aa0adf3b | Zenevix | Primary Pharmaceuticals, Inc. | Rainbow Gold Products, Inc. | 20200824 |
| ac0fff12-f9e5-2868-e053-2995a90acb8d | Dermalid | Primary Pharmaceuticals, Inc. | Rainbow Gold Products, Inc. | 20200804 |
| 8f880f4b-07b1-3650-e053-2995a90a5549 | Lidovix | Primary Pharmaceuticals, Inc. | Actavis Laboratories UT, Inc | Rainbow Gold | 20190807 |
| 09be2cbc-73bf-4894-add6-10e46c4471c9 | LIDODERM® (Lidocaine Patch 5%) | Lake Erie Medical DBA Quality Care Products LLC | 20190227 |
| d499efc5-8bc3-4dbc-9d85-fae57dd9263c | LIDODERM® (Lidocaine Patch 5%) | Unit Dose Services | 20171212 |
| 2d952516-e35b-4817-80d9-244f5c667379 | National Council for Prescription Drug Programs | 20130213 | |
| cd6934b2-0768-4dd1-b282-42ce75442c59 | National Council for Prescription Drug Programs | 20120724 | |
| b4fc5cae-10f5-4188-9410-9c84ee86c114 | National Council for Prescription Drug Programs | 20120724 | |
| f89a2432-8495-468a-9e78-1147096e1aec | National Council for Prescription Drug Programs | 20120724 | |
| 9d05f0dc-c357-4d7d-ac81-25142f222a4d | National Council for Prescription Drug Programs | 20120724 | |
| 98ce16d6-8304-472f-930f-45f0489755b6 | National Council for Prescription Drug Programs | 20120724 | |
| 96ac7312-97c7-4630-90cb-2232dbf4403e | National Council for Prescription Drug Programs | 20120724 | |
| 0ff0fee6-ce12-4055-918e-3052e7975c4d | National Council for Prescription Drug Programs | 20120724 | |
| 7c483781-8cbf-45b2-9302-3b6455997e46 | National Council for Prescription Drug Programs | 20120724 | |
| 55c5c9c9-41aa-4975-836a-2a5737cc9edd | National Council for Prescription Drug Programs | 20120724 | |
| 4f81901e-18e6-4fd0-b4c2-87314a6b7b7b | National Council for Prescription Drug Programs | 20120724 | |
| 49aa1173-6183-4dec-a6de-870352e07b69 | National Council for Prescription Drug Programs | 20120724 | |
| 3bcc6d1f-e5c3-4e12-a9ba-5420d7db077a | National Council for Prescription Drug Programs | 20120724 | |
| 2eb56bb5-6461-46f0-b1af-c2f98aaa0b97 | National Council for Prescription Drug Programs | 20120724 | |
| 26f7f71d-8120-4998-a053-0e2d1f7adf0a | National Council for Prescription Drug Programs | 20120724 | |
| 4e45cd6c-a777-4100-943b-985058bff75a | LIDODERM® (Lidocaine Patch 5%) | STAT Rx USA LLC | PSS World Medical Inc. | 20120202 |
| 55be87b4-a69b-4bfd-bf92-2949ec5e5dab | LIDODERM® (Lidocaine Patch 5%) | Dispensing Solutions, Inc. | 20111005 |
| 7ab30afe-4de2-4fe5-9e62-a484683fb93f | LIDODERM® (Lidocaine Patch 5%) | STAT RX USA LLC | 20110721 |
| 5ffefcdc-ebfa-4dc8-b484-719658da9d6d | Physicians Total Care, Inc. | 20100524 | |
| 18e420b9-0fd1-48d9-9a23-c1e29a5f629f | LIDODERM® (Lidocaine Patch 5%) | Rebel Distributors Corp. | 20100201 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | lidocaine | |
| ATC | S02DA | Analgesics and anesthetics | ATC1-4 | lidocaine | |
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | lidocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | lidocaine | |
| ATC | C01BB | Antiarrhythmics, class Ib | ATC1-4 | lidocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | S01HA | Local anesthetics | ATC1-4 | lidocaine | |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | lidocaine |
| FDASPL | N0000175426 | Antiarrhythmic | EPC | has_epc | lidocaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.05 MG/MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA020612 |
| NAMES | Prescribable Synonym | Lidoderm 5 % Medicated Patch |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |